XML 34 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 12 - Income Taxes
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
12.
  INCOME TAXES
 
The components of income before income taxes are as follows (in thousands):
  
   
Year Ended December 31,
 
   
2018
   
2017
   
2016
 
United States
  $
(13,151
)   $
(19,115
)   $
(14,431
)
Foreign
   
131,633
     
102,059
     
71,695
 
Income before income taxes
  $
118,482
    $
82,944
    $
57,264
 
 
The components of the income tax provision are as follows (in thousands):
 
   
Year Ended December 31,
 
   
2018
   
2017
   
2016
 
Current:
                       
Federal
  $
11,023
    $
31,025
    $
2,527
 
State
   
4
     
2
     
-
 
Foreign
   
2,992
     
1,967
     
2,013
 
Deferred:
                       
Federal
   
(797
)    
(15,426
)    
-
 
Foreign
   
(8
)    
173
     
4
 
Income tax provision
  $
13,214
    $
17,741
    $
4,544
 
 
The effective tax rate differs from the applicable U.S. statutory federal income tax rate as follows:
   
   
Year Ended December 31,
 
   
2018
   
2017
   
2016
 
U.S. statutory federal tax rate
   
21.0
%
   
35.0
%
   
34.0
%
Foreign income at lower rates
   
(22.0
)    
(41.2
)    
(41.1
)
Impact of the 2017 Tax Act:
                       
Remeasurement of deferred taxes
   
-
     
11.8
     
-
 
One-time deemed repatriation transition tax
   
0.6
     
50.5
     
-
 
Global intangible low-taxed income ("GILTI")
   
14.4
     
-
     
-
 
Changes in valuation allowance
   
-
     
(36.2
)    
11.0
 
Stock-based compensation
   
(1.1
)    
2.2
     
2.2
 
Other adjustments
   
(1.7
)    
(0.7
)    
1.8
 
Effective tax rate
   
11.2
%
   
21.4
%
   
7.9
%
 
The components of net deferred tax assets consist of the following (in thousands):
  
   
December 31,
 
   
2018
   
2017
 
Deferred tax assets:
               
R&D tax credits
  $
11,833
    $
10,331
 
Stock-based compensation
   
10,040
     
9,157
 
Deferred compensation
   
6,829
     
5,505
 
Depreciation and amortization
   
-
     
191
 
Net operating losses
   
1,133
     
1,377
 
Other expenses not currently deductible
   
1,852
     
1,924
 
Deferred tax assets, gross
   
31,687
     
28,485
 
Valuation allowance
   
(13,041
)    
(12,568
)
Deferred tax assets, net of valuation allowance
   
18,646
     
15,917
 
Deferred tax liabilities:
               
Depreciation and amortization
   
(711
)    
-
 
Undistributed foreign earnings
   
(1,105
)    
-
 
Deferred tax liabilities
   
(1,816
)    
-
 
Net deferred tax assets
  $
16,830
    $
15,917
 
 
 
2017
Tax Act
 
Under ASC
No.
740,
the effects of a new legislation are recognized upon enactment. Accordingly, the Company was required to recognize the tax effects of the
2017
Tax Act beginning in the
fourth
quarter of
2017.
 
On
December 22, 2017,
the SEC issued SAB
118,
which addressed the application of ASC
No.
740
in situations when a registrant did
not
have the necessary information available, prepared, or analyzed in reasonable detail to complete the accounting for certain income tax effects of the
2017
Tax Act. In accordance with SAB
118,
for matters that have
not
been completed, the Company would recognize provisional amounts to the extent that they were reasonably estimable. Any subsequent adjustments to the provisional amounts would be recorded to the income tax provision in the period when the analysis was complete. The Company was permitted to finalize the analysis within a
one
-year measurement period.
 
As of
December 31, 2017,
the Company had
not
completed the accounting for the tax effects of the
2017
Tax Act and recorded certain provisional amounts based on reasonable estimates. In
December 2018,
the Company finalized the analysis of the
2017
Tax Act and recorded certain adjustments to the provisional amounts, as discussed further below.
 
The Company expects further guidance
may
be forthcoming from the FASB and the SEC, as well as regulations, interpretations and rulings from federal and state tax agencies, which could result in additional impact and adjustments to the Company’s income tax provisions in future periods.              
 
Corporate Tax Rate and Remeasurement of Deferred Taxes:
 
The
2017
Tax Act reduces the corporate tax rate from
35%
to
21%,
effective
January 1, 2018.
Because ASC
No.
740
requires the effect of a change in tax laws to be recognized as of the date of enactment, the Company remeasured its deferred tax balance as of
December 22, 2017
and recorded a provisional amount of
$9.8
million to the income tax provision as a result of the remeasurement for the year ended
December 31, 2017.
In
December 2018,
the Company finalized the analysis and did
not
make any adjustment to the provisional amount recorded for the year ended
December 31, 2017.
 
Deemed Repatriation Transition Tax:
 
The
2017
Tax Act mandates a
one
-time deemed repatriation transition tax of post-
1986
undistributed foreign earnings and profits (“E&P”) on which U.S. income taxes were previously deferred. For the year ended 
December 31, 2017, 
the Company recorded a provisional amount of 
$41.9
 million related to the transition tax expense. After the utilization of R&D tax credits of 
$18.0
 million, the provisional transition tax liability was 
$23.9
million.  In
December 2018,
the Company finalized the analysis of the transition tax, and recorded an increase of
$1.3
million to the transition tax expense and a net increase of
$0.7
million to the transition tax liability.
 
As permitted by the
2017
Tax Act, the Company has elected to pay the transition tax liability of
$24.6
million in installments on an interest-free basis over
eight
years through
2025.
For the year ended
December 31, 2018,
the Company paid
$2.6
million of the transition tax. As of
December 31, 2018,
$1.3
million of the remaining transition tax was recorded in current accrued liabilities and
$20.7
million was recorded in long-term income tax liabilities.
 
Undistributed Earnings of Subsidiaries:
 
The Company previously considered the earnings in its non-U.S. subsidiaries to be indefinitely reinvested and, accordingly, recorded
no
deferred income taxes. Prior to the transition tax, the Company had an excess of the amount for financial reporting over the tax basis in its foreign subsidiaries including undistributed foreign earnings of
$390.2
million. While the transition tax resulted in the reduction of the excess of the amount for financial reporting over the tax basis in its foreign subsidiaries and subjected
$123.2
 million of undistributed foreign earnings to tax, an actual repatriation from its non-U.S. subsidiaries could be subject to additional foreign withholding taxes and U.S. state taxes.
 
The Company has analyzed its global working capital and cash requirements, and has determined that it plans to repatriate cash from its Bermuda subsidiary on an ongoing basis to fund its future U.S. based expenditures and dividends. For the other foreign subsidiaries, the Company expects to indefinitely reinvest undistributed earnings to fund foreign operations and their research and development. As of
December 31, 2018,
the Company recorded deferred taxes liabilities of
$1.1
million related to California state taxes, which were netted against deferred tax assets.
 
GILTI
:
 
The
2017
Tax Act subjects a U.S. parent shareholder to taxation of its GILTI, effective
January 1, 2018.
The GILTI inclusions impact companies that have foreign earnings generated without a large aggregate foreign fixed asset base and whose earnings are being taxed at a low tax rate. For the year ended
December 31, 2018,
the Company included
$81.1
million related to the GILTI provisions as additional Subpart F income, which was accounted for as a period cost.
 
Executive Compensation Deductions:
 
The
2017
Tax Act retains the
$1
million limitation on deductible compensation to covered employees, which include the Chief Executive Officer and
four
other highest paid officers, under IRC Section
162
(m). However, it eliminates the exception for performance-based cash or stock compensation and expands the definition of covered employees to include the Chief Financial Officer. Accordingly, beginning
January 1, 2018,
the deductible compensation to covered employees is generally subject to the
$1
million limitation.
 
Release of Valuation Allowance
 
Management periodically evaluates the realizability of the Company’s deferred tax assets based on all available evidence. The realizability of the Company’s net deferred tax assets is dependent on its ability to generate sufficient future taxable income during periods prior to the expiration of tax attributes to fully utilize these assets. The Company maintained a full valuation allowance on its U.S. deferred tax assets as of the
third
quarter of
2017.
  In the
fourth
quarter of
2017,
the Company assessed the realizability of the deferred tax assets and concluded that it was more likely than
not
that its federal deferred tax assets would be realizable, due principally to the enactment of the
2017
Tax Act.
 
In accordance with ASC
No.
740,
management considered all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets was needed. The Company’s conclusion was primarily driven by the following positive evidence:
 
 
The Company forecasted taxable income in the U.S. in future periods.  The enactment of GILTI will result in additional Subpart F income each year.
 
Executive performance-based equity awards are now subject to the Section
162
(m) deduction limitation.
 
The Company has a history of utilizing all federal tax attributes before expiration.
 
As a result, the Company released
$21.6
million of valuation allowance on federal deferred tax assets, which was recorded as a benefit in the income tax provision in the
fourth
quarter of
2017.
The Company continues to maintain a full valuation allowance on the deferred tax assets in California, primarily due to a low apportionment factor and the amount of R&D tax credits generated is greater than the amount utilized.
  
Other Income Tax Provision Matters
 
As of
December 31, 2018,
the Company did
not
have federal net operating loss carryforwards. As of
December 31, 2018,
the state net operating loss carryforwards for income tax purposes were
$16.2
million, which will expire beginning in
2027.
 
As of
December 31, 2018,
the Company had
no
R&D tax credit carryforwards for federal income tax purposes, and
$24.1
million for state income tax purposes, which can be carried forward indefinitely.
 
In the event of a change in ownership, as defined under federal and state tax laws, the Company's net operating loss and tax credit carryforwards could be subject to annual limitations.  The annual limitations could result in the expiration of the net operating loss and tax credit carryforwards prior to utilization.
 
In
July 2018,
the U.S. Ninth Circuit Court of Appeals overturned the U.S. Tax Court’s unanimous
2015
decision in 
Altera v. Commissioner
, holding that the Internal Revenue Service ("IRS") did
not
violate the rule-making procedures required by the Administrative Procedures Act. In the case
the taxpayer challenged IRS regulations that required participants in qualified cost sharing arrangements to share stock based compensation costs. The Tax Court had invalidated those regulations, in part because the Treasury Department failed to adequately consider significant taxpayer comments when adopting them. In
August 2018,
the U.S. Ninth Circuit Court of Appeals withdrew its
July 2018
opinion. At this time, the Treasury Department has
not
withdrawn the requirement from its regulations to include stock-based compensation in the cost pool to be shared under a cost-sharing arrangement. Due to the uncertainty surrounding the status of the current regulations, questions related to the scope of potential benefits, and the risk of the Tax Court’s decision being overturned upon appeal, the Company has
not
recorded any adjustments as of
December 31, 2018.
The Company will continue to monitor developments related to this case and the potential impact on its financial statements.
 
At
December 31, 2018,
the Company had
$20.5
million of unrecognized tax benefits,
$12.8
million of which would affect its effective tax rate if recognized after considering the valuation allowance. At
December 31, 2017,
the Company had
$16.3
million of unrecognized tax benefits,
$9.1
million of which would affect its effective tax rate if recognized after considering the valuation allowance. 
 
A reconciliation of the gross unrecognized tax benefits is as follows (in thousands): 
 
Balance as of January 1, 2016
  $
12,093
 
Increase for tax position of prior year
   
243
 
Increase for tax position of current year
   
2,095
 
Balance as of December 31, 2016
   
14,431
 
Increase for tax position of prior year
   
169
 
Increase for tax position of current year
   
2,360
 
Decrease due to lapse of statute of limitation
   
(688
)
Balance as of December 31, 2017
   
16,272
 
Increase for tax position of prior year
   
1,474
 
Increase for tax position of current year
   
2,957
 
Decrease due to lapse of statute of limitation
   
(212
)
Balance as of December 31, 2018
  $
20,491
 
 
The Company recognizes interest and penalties, if any, related to uncertain tax positions in its income tax provision. As of
December 31, 2018
and
2017,
the Company has
$0.9
million and
$0.5
million, respectively, of accrued interest related to uncertain tax positions, which were recorded in long-term income tax liabilities in the Consolidated Balance Sheets.
 
Uncertain tax positions relate to the allocation of income and deductions among the Company’s global entities and to the determination of the research and development tax credit. It is reasonably possible that over the next
twelve
-month period, the Company
may
experience increases or decreases in its unrecognized tax benefits. However, it is
not
possible to determine either the magnitude or the range of increases or decreases at this time.
 
The Company currently has reduced tax rates in its subsidiaries in Chengdu and Hangzhou, China for performing research and development activities through
2020
and
2019,
respectively. In addition, the Company had a tax holiday in Switzerland, which expired on
December 31, 2018  
The tax holiday and tax incentives had an insignificant impact on earnings per share for the periods presented.
 
Income Tax Examination
 
The Company is subject to examination of its income tax returns by the IRS and other tax authorities. The Company’s U.S. federal income tax return for the year ended
December 31, 2014
was under examination by the IRS in
2016.
In
January 2017,
the IRS completed its examination with
no
adjustments.